Antihistamines, a possible risk factor for alzheimer's disease

References 

1. In: Archives. Brentwood, NY: Pilgrim State Psychiatric Center; 1993;
2. Prohovnik I, Dwork AJ, Kaufman MA, Willson N. Alzheimer-type neuropathology in elderly schizophrenic patients. Schiz Bull. 1993;19:805–816
3. Soustek Z. Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralblatt für Allgemeine Pathologie and Pathologische Anatomic. 1989;135:25–32
4. Constantinides J, Wisniewski HM, Wegiel J, Bobinski M, Tornowski M. Neuroleptics and the formation of neurofibrillary tangles in brains of elderly schizophrenics. 1994; Manuscript in preparation
5. Barondes SH. Thinking about Prozac. Science. 1994;263:1102–1103
   • MEDLINE
6. In: Physicians' Desk Reference. Montvale, New Jersey: Medical Economics Data Production Co; 1994;p. 2287–2288
7. Lieberman JA. Understanding the mechanism of action of atypical antipsychotic drugs. Br J Psychiatry. 1993;163(suppl 22):7–18
8. Kaufman MA, Dwork AJ, Prohovnik I, Willson N. Alzheimer's disease in ageing schizophrenics. (abstract) In: Proceedings of XIth International Congress of Neuropathology. Kyoto, Japan. 1990;p. 322; V-C-6
9. Price DL, Koliatsos VE, Martin LJ, et al.  Model systems relevant to Alzheimer's disease. In:  Iqbal K,  McLachlan DK,  Winblad B,  Wisniewski HM editor. Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. Chichester: John Wiley and Sons; 1991;p. 465–471
10. Cookson J. Side-effects of antidepressants. Br J Psychiatry. 1993;163(suppl 20):20–24
11. Blanchard JJ, Neale JM. The neuropsychological signature of schizophrenia, generalized or differential deficit?. Am J Psychiatry. 1994;151:40–48
    • MEDLINE
12. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia. J Abnorm Psychol. 1989;98:367–380
    • MEDLINE
    • CrossRef
13. Fayen M, Goldman MB, Moulthrop MA, Luchins DJ. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms. Am J Psychiatry. 1988;145:483–486
    • MEDLINE
14. Hitri A, Craft RB, Fallon J, Sethi R, Sinha D. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients. Psychopharm Bull. 1987;23:33–37
15. Tune LE, Strauss ME, Lew MF, Breitlinger E, Coyle JT. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry. 1982;139:1460–1462
    • MEDLINE
16. Strauss ME, Reynolds KS, Jayaram G, Tune LE. Effects of anticholinergic medication on memory in schizophrenia. Schiz Res. 1990;3:127–129
17. Perlick D, Stastny P, Katz I, Mayer M, Mattis S. Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry. 1986;143:230–232
    • MEDLINE